1. Home
  2. MDGL vs EPRT Comparison

MDGL vs EPRT Comparison

Compare MDGL & EPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • EPRT
  • Stock Information
  • Founded
  • MDGL 2011
  • EPRT 2016
  • Country
  • MDGL United States
  • EPRT United States
  • Employees
  • MDGL N/A
  • EPRT N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • EPRT Real Estate Investment Trusts
  • Sector
  • MDGL Health Care
  • EPRT Real Estate
  • Exchange
  • MDGL Nasdaq
  • EPRT Nasdaq
  • Market Cap
  • MDGL 6.1B
  • EPRT 6.2B
  • IPO Year
  • MDGL N/A
  • EPRT 2018
  • Fundamental
  • Price
  • MDGL $314.31
  • EPRT $31.61
  • Analyst Decision
  • MDGL Strong Buy
  • EPRT Buy
  • Analyst Count
  • MDGL 9
  • EPRT 13
  • Target Price
  • MDGL $420.63
  • EPRT $34.98
  • AVG Volume (30 Days)
  • MDGL 282.4K
  • EPRT 2.0M
  • Earning Date
  • MDGL 08-06-2025
  • EPRT 07-23-2025
  • Dividend Yield
  • MDGL N/A
  • EPRT 3.79%
  • EPS Growth
  • MDGL N/A
  • EPRT N/A
  • EPS
  • MDGL N/A
  • EPRT 1.16
  • Revenue
  • MDGL $317,383,000.00
  • EPRT $475,463,000.00
  • Revenue This Year
  • MDGL $286.17
  • EPRT $21.95
  • Revenue Next Year
  • MDGL $64.17
  • EPRT $17.02
  • P/E Ratio
  • MDGL N/A
  • EPRT $26.81
  • Revenue Growth
  • MDGL N/A
  • EPRT 25.32
  • 52 Week Low
  • MDGL $200.63
  • EPRT $27.44
  • 52 Week High
  • MDGL $377.46
  • EPRT $34.88
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 64.53
  • EPRT 45.79
  • Support Level
  • MDGL $284.02
  • EPRT $31.41
  • Resistance Level
  • MDGL $311.21
  • EPRT $32.25
  • Average True Range (ATR)
  • MDGL 11.94
  • EPRT 0.60
  • MACD
  • MDGL 2.74
  • EPRT -0.11
  • Stochastic Oscillator
  • MDGL 100.00
  • EPRT 37.89

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About EPRT Essential Properties Realty Trust Inc.

Essential Properties Realty Trust Inc is a real estate investment trust. It is an internally managed real estate company acquires, owns and manages single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses. The Company generally invests in and leases freestanding, single-tenant commercial real estate facilities where a tenant services its customers and conducts activities that are essential to the generation of the tenant's sales and profits.

Share on Social Networks: